taurine has been researched along with Short Bowel Syndrome in 5 studies
Short Bowel Syndrome: A malabsorption syndrome resulting from extensive operative resection of the SMALL INTESTINE, the absorptive region of the GASTROINTESTINAL TRACT.
Excerpt | Relevance | Reference |
---|---|---|
" Incidence and type of sepsis were reviewed for 8 to 12 months pre- (when heparin was used) and 2 to 33 months postintroduction of the taurolidine catheter lock." | 3.78 | Significant reduction in central venous catheter-related bloodstream infections in children on HPN after starting treatment with taurolidine line lock. ( Brind, J; Chu, HP; Hill, S; Tomar, R, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Merras-Salmio, L | 1 |
Mutanen, A | 1 |
Ylinen, E | 1 |
Rintala, R | 1 |
Koivusalo, A | 1 |
Pakarinen, MP | 1 |
Chu, HP | 1 |
Brind, J | 1 |
Tomar, R | 1 |
Hill, S | 1 |
Schneider, SM | 1 |
Joly, F | 1 |
Gehrardt, MF | 1 |
Badran, AM | 1 |
Myara, A | 1 |
Thuillier, F | 1 |
Coudray-Lucas, C | 1 |
Cynober, L | 1 |
Trivin, F | 1 |
Messing, B | 1 |
Meehan, JJ | 1 |
Georgeson, KE | 1 |
Helms, RA | 1 |
Storm, MC | 1 |
Christensen, ML | 1 |
Hak, EB | 1 |
Chesney, RW | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Expanded Access Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Liver Injury in Children[NCT02925520] | 0 participants | Expanded Access | No longer available | ||||
Compassionate Use of an Intravenous Fat Emulsion Comprised of Fish Oil in the Treatment of Parenteral Nutrition Induced Liver Injury in Infants[NCT00738101] | 293 participants (Actual) | Interventional | 2008-09-30 | Completed | |||
Research Study of an Intravenous Fat Emulsion Comprised of Fish Oils (Omegaven) in the Treatment of Parenteral Nutrition (PN) Induced Liver Injury[NCT01089426] | 90 participants (Actual) | Interventional | 2008-09-30 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
To describe proportion of infants who died secondary to any cause, related or unrelated to Fish Oil Emulsion. (NCT00738101)
Timeframe: From initiation to end of study (End of Study : Discontinuation of Fish Oil Emulsion, Death, Transplant, or Discharge from the hospital, whichever is achieved first, up to 5 years).
Intervention | Participants (Count of Participants) |
---|---|
Fish Oil Emulsion Arm | 30 |
To describe number and percentage of infants who died secondary to any cause, related or unrelated to Fish Oil Emulsion. (NCT00738101)
Timeframe: Anytime from initiation of study to discharge from the hospital.
Intervention | Participants (Count of Participants) |
---|---|
Fish Oil Emulsion Arm | 40 |
The Z-score indicated the number of standard deviations away from the mean. A weight Z-score of 0 is equal to the mean. A weight Z-score of ≤ -2 indicates an underweight status, while a weight Z-score of ≥ 2 indicates overweight or obese status. (NCT00738101)
Timeframe: From initiation to end of study (End of Study : Discontinuation of Fish Oil Emulsion, Death, Transplant, or Discharge from the hospital, whichever is achieved first, up to 5 years).
Intervention | z-score (Mean) |
---|---|
Fish Oil Emulsion Arm | -1.48 |
To describe the number and percentage of infants who required liver or multi-visceral transplant. (NCT00738101)
Timeframe: From initiation to end of study (End of Study : Discontinuation of Fish Oil Emulsion, Death, Transplant, or Discharge from the hospital, whichever is achieved first, up to 5 years).
Intervention | Participants (Count of Participants) |
---|---|
Fish Oil Emulsion Arm | 2 |
Time in days from the initiation of fish oil emulsions (initiation of study) until resolution of cholestasis as defined by serum conjugated bilirubin≤ 2 mg/dL prior to EOS (end of study). (NCT00738101)
Timeframe: From initiation to end of study (End of Study : Discontinuation of Fish Oil Emulsion, Death, Transplant, or Discharge from the hospital, whichever is achieved first, up to 5 years).
Intervention | Days (Mean) |
---|---|
Fish Oil Emulsion Arm | 38.02 |
1 trial available for taurine and Short Bowel Syndrome
Article | Year |
---|---|
Taurine status and response to intravenous taurine supplementation in adults with short-bowel syndrome undergoing long-term parenteral nutrition: a pilot study.
Topics: Adult; Amino Acids; Bile Acids and Salts; Cholestasis, Intrahepatic; Chronic Disease; Epidemiologic | 2006 |
4 other studies available for taurine and Short Bowel Syndrome
Article | Year |
---|---|
Pediatric Intestinal Failure: The Key Outcomes for the First 100 Patients Treated in a National Tertiary Referral Center During 1984-2017.
Topics: Catheter-Related Infections; Child; Child, Preschool; Digestive System Surgical Procedures; Female; | 2018 |
Significant reduction in central venous catheter-related bloodstream infections in children on HPN after starting treatment with taurolidine line lock.
Topics: Adolescent; Adult; Anti-Infective Agents; Anticoagulants; Catheter-Related Infections; Catheterizati | 2012 |
Prevention of liver failure in parenteral nutrition-dependent children with short bowel syndrome.
Topics: Bacterial Translocation; Catheters, Indwelling; Child; Child, Preschool; Cholestasis; Clinical Proto | 1997 |
Prevention of liver failure in parenteral nutrition-dependent children with short bowel syndrome.
Topics: Bacterial Translocation; Catheters, Indwelling; Child; Child, Preschool; Cholestasis; Clinical Proto | 1997 |
Prevention of liver failure in parenteral nutrition-dependent children with short bowel syndrome.
Topics: Bacterial Translocation; Catheters, Indwelling; Child; Child, Preschool; Cholestasis; Clinical Proto | 1997 |
Prevention of liver failure in parenteral nutrition-dependent children with short bowel syndrome.
Topics: Bacterial Translocation; Catheters, Indwelling; Child; Child, Preschool; Cholestasis; Clinical Proto | 1997 |
Prevention of liver failure in parenteral nutrition-dependent children with short bowel syndrome.
Topics: Bacterial Translocation; Catheters, Indwelling; Child; Child, Preschool; Cholestasis; Clinical Proto | 1997 |
Prevention of liver failure in parenteral nutrition-dependent children with short bowel syndrome.
Topics: Bacterial Translocation; Catheters, Indwelling; Child; Child, Preschool; Cholestasis; Clinical Proto | 1997 |
Prevention of liver failure in parenteral nutrition-dependent children with short bowel syndrome.
Topics: Bacterial Translocation; Catheters, Indwelling; Child; Child, Preschool; Cholestasis; Clinical Proto | 1997 |
Prevention of liver failure in parenteral nutrition-dependent children with short bowel syndrome.
Topics: Bacterial Translocation; Catheters, Indwelling; Child; Child, Preschool; Cholestasis; Clinical Proto | 1997 |
Prevention of liver failure in parenteral nutrition-dependent children with short bowel syndrome.
Topics: Bacterial Translocation; Catheters, Indwelling; Child; Child, Preschool; Cholestasis; Clinical Proto | 1997 |
Cysteine supplementation results in normalization of plasma taurine concentrations in children receiving home parenteral nutrition.
Topics: Amino Acids, Sulfur; Child; Child, Preschool; Cysteine; Dose-Response Relationship, Drug; Female; Hu | 1999 |